Phreesia Reports 10% Revenue Growth to $129.5M in Fiscal Q2 2027
Phreesia posted a 10% revenue increase to $129.5 million in fiscal Q2 2027, maintaining full-year guidance and achieving its fifth straight quarter…
Phreesia posted a 10% revenue increase to $129.5 million in fiscal Q2 2027, maintaining full-year guidance and achieving its fifth straight quarter…
Nanox shares face pressure as a $40.7 million impairment charge and rising operating losses overshadow revenue growth, forcing the company to seek…
Oxford Nanopore Technologies (ONT.L) stock staged a comeback from beaten-down levels, reflecting renewed investor appetite for the UK healthcare tech name and…
FinThrive's earnings drop and credit line drawdown under Clearlake Capital points to rising financial strain in healthcare technology and private credit markets.